Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)

Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group

doi:10.12290/xhyxzz.2021-0555

Xiehe Yixue Zazhi (Nov 2021)

Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)

Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group

Affiliations

Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group

DOI: https://doi.org/10.12290/xhyxzz.2021-0555
Journal volume & issue: Vol. 12, no. 6
pp. 902 – 912

Abstract

Read online

In recent years, research on the clinical phenotypes, new classifications, modified functional tests, biomarkers and management experience for patients with Gitelman syndrome (GS)has made a lot of progress in China. Based on evidence-based medicine, this consensus summarizes aspects related to GS, including clinical manifestations and classification, diagnosis, treatment strategies, and management of chronic complications and comorbidity. This consensus provides an important reference for the diagnosis and treatment of GS.

Published in Xiehe Yixue Zazhi

ISSN: 1674-9081 (Print)
Publisher: Editorial Office of Medical Journal of Peking Union Medical College Hospital
Country of publisher: China
LCC subjects: Medicine
Website: https://xhyxzz.pumch.cn/indexen.htm

About the journal

Abstract

Keywords